A black line drawing of a mother putting a face mask on a child with a white background

SARS-CoV-2 Antigens Leaking from Gut to Blood Might Trigger MIS-C

Researchers find traces of SARS-CoV-2 in the stool and blood of kids with the post–COVID-19 inflammatory disorder, and signs of increased intestinal permeability.

SARS-CoV-2 Antigens Leaking from Gut to Blood Might Trigger MIS-C

Researchers find traces of SARS-CoV-2 in the stool and blood of kids with the post–COVID-19 inflammatory disorder, and signs of increased intestinal permeability.

Home
Subjects
inflammation, disease & medicine, drug development

inflammation, disease & medicine, drug development

Pharma Looks to Inflammasome Inhibitors as All-Around Therapies

Rachael Moeller Gorman | Apr 1, 2021 | 10+ min read

Many major biopharmaceutical companies are developing or acquiring drugs that target the NLRP3 inflammasome, a large intracellular complex that researchers say can spark inflammation and stoke diseases of lifestyle and aging.